{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:33Z","timestamp":1786118913136,"version":"build-2736575974"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/bor.0b013e328315a05b","type":"journal-article","created":{"date-parts":[[2008,10,21]],"date-time":"2008-10-21T03:09:50Z","timestamp":1224558590000},"page":"639-647","source":"Crossref","is-referenced-by-count":25,"title":["Metabolic myopathies: a guide and update for clinicians"],"prefix":"10.1097","volume":"20","author":[{"given":"Marian L","family":"Burr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew JK","family":"\u00d6st\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210128","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.bor.0000245729.17759.f2","article-title":"Mitochondrial myopathies","volume":"18","author":"DiMauro","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"R2-2-20210128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0887-8994(99)00133-2","article-title":"Metabolic myopathies: a clinical approach: part I","volume":"22","author":"Darras","year":"2000","journal-title":"Pediatr Neurol"},{"key":"R3-2-20210128","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/mus.1103","article-title":"Muscle glycogenoses","volume":"24","author":"DiMauro","year":"2001","journal-title":"Muscle Nerve"},{"key":"R4-2-20210128","first-page":"35","article-title":"Muscle glycogenoses: an overview","volume":"26","author":"DiMauro","year":"2007","journal-title":"Acta Myol"},{"key":"R5-2-20210128","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1073\/pnas.45.6.791","article-title":"A functional disorder of muscle associated with the absence of phosphorylase","volume":"45","author":"Mommaerts","year":"1959","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-2-20210128","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00002281-199911000-00003","article-title":"Metabolic and mitochondrial myopathies","volume":"11","author":"Wortmann","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"R7-2-20210128","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/brain\/109.6.1087","article-title":"The second wind phenomenon in McArdle's disease","volume":"109","author":"Braakhekke","year":"1986","journal-title":"Brain"},{"key":"R9-2-20210128","first-page":"304","article-title":"Concerning idiopathic hypertrophy of the heart [in Dutch]","volume":"76","author":"Pompe","year":"1932","journal-title":"Ned Tijdschr Geneeskd"},{"key":"R10-2-20210128","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of nonclassic Pompe's disease: a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J Neurol"},{"key":"R12-2-20210128","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","article-title":"Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects","volume":"25","author":"Bonnefont","year":"2004","journal-title":"Mol Aspects Med"},{"key":"R13-2-20210128","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1468-1331.2006.01482.x","article-title":"Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders","volume":"13","author":"Angelini","year":"2006","journal-title":"Eur J Neurol"},{"key":"R14-2-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410270214","article-title":"Metabolic causes of myoglobinuria","volume":"27","author":"Tonin","year":"1990","journal-title":"Ann Neurol"},{"key":"R15-2-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ymgme.2006.08.004","article-title":"Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency","volume":"89","author":"Isackson","year":"2006","journal-title":"Mol Genet Metab"},{"key":"R16-2-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2007.09.015","article-title":"Clinical features and new molecular findings in carnitine palmitoyltransferase II (CPT II) deficiency","volume":"266","author":"Corti","year":"2008","journal-title":"J Neurol Sci"},{"key":"R17-2-20210128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archneur.62.1.37","article-title":"Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects","volume":"62","author":"Deschauer","year":"2005","journal-title":"Arch Neurol"},{"key":"R18-2-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejim.2007.04.025","article-title":"Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency","volume":"19","author":"Deutsch","year":"2008","journal-title":"Eur J Intern Med"},{"key":"R19-2-20210128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2008.03.005","article-title":"Vigabatrin, lamotrigine, topiramate and serum carnitine levels","volume":"39","author":"Zelnik","year":"2008","journal-title":"Pediatr Neurol"},{"key":"R20-2-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1525-139X.2006.00180.x","article-title":"Dialysis-related carnitine disorder","volume":"19","author":"Hedayati","year":"2006","journal-title":"Semin Dial"},{"key":"R21-2-20210128","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awm135","article-title":"ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"130","author":"Olsen","year":"2007","journal-title":"Brain"},{"key":"R22-2-20210128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/japplphysiol.00185.2007","article-title":"AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects","volume":"103","author":"Fischer","year":"2007","journal-title":"J Appl Physiol"},{"key":"R23-2-20210128","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1469-7793.2001.t01-1-00881.x","article-title":"Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans","volume":"533","author":"Tarnopolsky","year":"2001","journal-title":"J Physiol"},{"key":"R24-2-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00415-008-0530-6","article-title":"AMP deaminase deficiency in skeletal muscle is unlikely to be of clinical relevance","volume":"255","author":"Hanisch","year":"2008","journal-title":"J Neurol"},{"key":"R25-2-20210128","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mus.20341","article-title":"Muscle cramps","volume":"32","author":"Miller","year":"2005","journal-title":"Muscle Nerve"},{"key":"R26-2-20210128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/bmb\/ldm014","article-title":"Creatine kinase monitoring in sport medicine","volume":"81\u201382","author":"Brancaccio","year":"2007","journal-title":"Br Med Bull"},{"key":"R27-2-20210128","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/01.bor.0000143441.27065.bc","article-title":"Is it really myositis? A consideration of the differential diagnosis","volume":"16","author":"Nirmalananthan","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"R28-2-20210128","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00007611-200405000-00023","article-title":"Mitochondrial encephalomyopathy with lactic acidosis and strokelike episodes (MELAS): a mitochondrial disorder presents as fibromyalgia","volume":"97","author":"DeSouza","year":"2004","journal-title":"South Med J"},{"key":"R29-2-20210128","first-page":"974","article-title":"Silent exercise-induced enzymatic myopathies at rest in adults. A cause of confusion with fibromyalgia","volume":"21","author":"Dupond","year":"1992","journal-title":"Presse Med"},{"key":"R30-2-20210128","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1258\/0004563041201554","article-title":"McArdle's disease diagnosed following statin-induced myositis","volume":"41","author":"Livingstone","year":"2004","journal-title":"Ann Clin Biochem"},{"key":"R31-2-20210128","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1590\/S0004-282X2007000500020","article-title":"McArdle disease with rhabdomyolysis induced by rosuvastatin: case report","volume":"65","author":"Lorenzoni","year":"2007","journal-title":"Arq Neuropsiquiatr"},{"key":"R32-2-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mus.20567","article-title":"Genetic risk factors associated with lipid-lowering drug-induced myopathies","volume":"34","author":"Vladutiu","year":"2006","journal-title":"Muscle Nerve"},{"key":"R33-2-20210128","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archinte.166.14.1519","article-title":"Presymptomatic neuromuscular disorders disclosed following statin treatment","volume":"166","author":"Tsivgoulis","year":"2006","journal-title":"Arch Intern Med"},{"key":"R34-2-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nmd.2007.08.008","article-title":"Myopathy associated with statin therapy","volume":"18","author":"Hilton-Jones","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"R35-2-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10072-006-0701-0","article-title":"High plasma creatine kinase: review of the literature and proposal for a diagnostic algorithm","volume":"27","author":"Morandi","year":"2006","journal-title":"Neurol Sci"},{"key":"R36-2-20210128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jmri.20806","article-title":"Musculoskeletal spectroscopy","volume":"25","author":"Boesch","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"R37-2-20210128","first-page":"9","article-title":"P-31 magnetic resonance spectroscopy: a tool for diagnostic purposes and pathophysiological insights in muscle diseases","volume":"56","author":"Mattei","year":"2004","journal-title":"Reumatismo"},{"key":"R38-2-20210128","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1212\/WNL.56.12.1733","article-title":"A nonischemic forearm exercise test for the screening of patients with exercise intolerance","volume":"56","author":"Hogrel","year":"2001","journal-title":"Neurology"},{"key":"R39-2-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/humu.9474","article-title":"A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients","volume":"28","author":"Rubio","year":"2007","journal-title":"Hum Mutat"},{"key":"R40-2-20210128","first-page":"53","article-title":"McArdle disease: molecular genetic update","volume":"26","author":"Andreu","year":"2007","journal-title":"Acta Myol"},{"key":"R41-2-20210128","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1249\/01.mss.0000187413.41416.7e","article-title":"Recurrent rhabdomyolysis in a collegiate athlete: a case report","volume":"38","author":"Krivickas","year":"2006","journal-title":"Med Sci Sports Exerc"},{"key":"R43-2-20210128","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10545-007-0666-z","article-title":"Expanded newborn screening in Europe 2007","volume":"30","author":"Bodamer","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"R45-2-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneur.59.1.97","article-title":"Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study","volume":"59","author":"Vorgerd","year":"2002","journal-title":"Arch Neurol"},{"key":"R47-2-20210128","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mus.20937","article-title":"Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease","volume":"37","author":"Martinuzzi","year":"2008","journal-title":"Muscle Nerve"},{"key":"R48-2-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/JSM.0b013e3180f6168c","article-title":"Favorable responses to acute and chronic exercise in McArdle patients","volume":"17","author":"Mate-Munoz","year":"2007","journal-title":"Clin J Sport Med"},{"key":"R49-2-20210128","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1249\/01.mss.0000177446.97671.2a","article-title":"Exercise and training in mitochondrial myopathies","volume":"37","author":"Taivassalo","year":"2005","journal-title":"Med Sci Sports Exerc"},{"key":"R50-2-20210128","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ana.20881","article-title":"Aerobic conditioning: an effective therapy in McArdle's disease","volume":"59","author":"Haller","year":"2006","journal-title":"Ann Neurol"},{"key":"R51-2-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10545-008-0844-7","article-title":"PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders","volume":"31","author":"Djouadi","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"R53-2-20210128","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/01.WNL.0000078195.05396.20","article-title":"Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency","volume":"61","author":"Orngreen","year":"2003","journal-title":"Neurology"},{"key":"R54-2-20210128","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"R55-2-20210128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2006.02.035","article-title":"Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease","volume":"149","author":"Kishnani","year":"2006","journal-title":"J Pediatr"},{"key":"R56-2-20210128","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet Med"},{"key":"R57-2-20210128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","article-title":"Recombinant human alpha-glucosidase from rabbit milk in Pompe patients","volume":"356","author":"Van Den Hout","year":"2000","journal-title":"Lancet"},{"key":"R58-2-20210128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10545-007-0519-9","article-title":"Glycogen storage disease types I and II: treatment updates","volume":"30","author":"Koeberl","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"R60-2-20210128","first-page":"49","article-title":"Progress and problems when considering gene therapy for GSD-II","volume":"26","author":"Kiang","year":"2007","journal-title":"Acta Myol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e328315a05b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:07:15Z","timestamp":1786036035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200811000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e328315a05b","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}